The American Association for Respiratory Care Corporate Partner Program is comprised of best-in-class organizations interested in supporting the goals and work of the Association. The program aims to give respiratory care providers information, insights, and innovative approaches to improve performance and advance the health of their patients. Together, this move will strengthen each of us in all of our endeavors. It is with great pride that we present our Corporate Partners.
Cardinal Health, (NYSE:CAH), is the leading provider of respiratory products to health care providers in the United States. Cardinal Health businesses develop, manufacture, package and market products for patient care; develop drug-delivery technologies; distribute pharmaceuticals, medical-surgical and laboratory supplies; and offer consulting and other services that improve quality and efficiency in health care. Headquartered in Dublin, Ohio, Cardinal Health employs approximately 50,000 people on five continents and produces annual revenues of more than $47 billion. Cardinal Health is ranked number 19 on the current Fortune 500 list and was named one of “The World’s Best”companies by Forbes magazine in 2002.
Sepracor Inc. is widely recognized in the respiratory care category as the makers of XOPENEX® (levalbuterol HCl) inhalation solution for the treatment or prevention of bronchospasm in patients 6 years of age and older with reversible obstructive airway disease, such as asthma. Sepracor is a research-based pharmaceutical company dedicated to treating and preventing human disease through the discovery, development, and commercialization of innovative pharmaceutical products that are directed toward serving unmet medical needs. Sepracor's drug development program has yielded an extensive portfolio of pharmaceutical compound candidates, including candidates for the treatment of respiratory, urology, and central nervous system disorders. Sepracor’s corporate headquarters are located in Marlborough, MA.
Masimo, innovator and leader of motion and low perfusion tolerant pulse oximetry, a technology that noninvasively measures arterial oxygen saturation, is committed to improving patient outcomes and reducing cost of care by working with dedicated hospital staff to convert health care institutions around the world to Masimo SET pulse oximetry technology. They are accomplishing this goal by directly marketing complete pulse oximetry solutions to hospitals, as well as by partnering with patient monitoring companies to create innovative, cost-effective acquisition programs for Masimo SET products. Masimo Corporation is located in Irvine, California.
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies. The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquarted in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and approximately 39,800 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
Boehringer Ingelheim Pharmaceuticals, Inc. markets human prescription medicines that treat major unmet medical needs across the primary categories of respiratory (Spiriva® Handihaler®, Combivent®, Atrovent®), cardiovascular (Aggrenox®, Catapres TTS®, Micardis®, Micardis® HCT, neurological (Mirapex®), urological (Flomax®), and viral disease states (Aptivus®, Viramune®).
In 2007, Boehringer Ingelheim posted net sales of US $15.0 billion (10.9 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development. For more information, please visit http://us.boehringer-ingelheim.com.
Covidien, formerly Tyco Healthcare, is a global $10 billion manufacturer of leading medical devices and supplies, imaging products and pharmaceuticals. The Company employs more than 43,000 people worldwide and is dedicated to working with medical professionals to improve patient outcomes. Its portfolio of leading brands includes Nellcor, Puritan Bennett, Mallinckrodt, Autosuture, Kendall, Syneture and Valleylab.
Monaghan Medical Corporation is a global leader in the manufacture and sale of aerosol drug delivery devices and asthma management products as well as a supplier to major pharmaceutical companies involved with respiratory medicine in the United States . The company's strength lies in its science based approach to developing cost efficient, outcome based products for aerosolized drug delivery including the well-known brand names AeroChamber MAX ® Valved Holding Chamber (VHC), AeroChamber Plus ® Z STAT ® anti-static Valved Holding Chamber (aVHC), AeroEclipse ® II Breath Actuated Nebulizer (BAN), AeroVent ® Collapsible Holding Chamber (CHC), TruZone ® Peak Flow Meter (PFM) and Doc Monaghan ™ . Detailed clinical and contact information can be found on the company's website, www.monaghanmed.com.
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people’s lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of “sense and simplicity”. Headquartered in the Netherlands, Philips employs approximately 128,000 employees in more than 60 countries worldwide. With sales of USD 42 billion (€27 billion) in 2007, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.
IKARIA™ (formerly known as INO Therapeutics) is a uniquely positioned, fully integrated pharmaceutical company. The company possesses strong scientific capabilities in both pharmaceuticals and drug delivery devices, such as our flagship product INOmax® (nitric oxide) for inhalation and the INOvent®. The focus of the company is upon attaining leadership in the in-patient critical care market, by bringing to our customers innovative products that meet the needs of the critical care patient and the professionals who care for them.
Maquet.Inc. is the U.S. sales and service unit of MAQUET and a subsidiary of the GETINGE Group of companies. MAQUET provides market-leading medical solutions and services for Surgical Workplaces, Critical Care and Cardiovascular environments, offering a product portfolio designed for efficient workflows, safety and the improvement of patient outcomes.
Worldwide, MAQUET is the leading provider in the field of ventilation, with SERVO® the number one ventilation brand. The unmatched flexibility of the SERVO-i ventilation platform is designed for sensitivity and response for all patient categories and acuity levels in the NICU, PICU and adult ICU.
Dräeger Medical AG & Co. KG is one of the world’s leading manufacturers of medical equipment, the largest division of Drägerwerk AG (history dates back to 1889) and a 65:35 joint venture company between Drägerwerk AG and Siemens AG. The Company offers products, services and integrated CareArea™ Solutions throughout the patient care process—Emergency Care, Perioperative Care, Critical Care, Perinatal Care and Home Care. Dräger Medical provides innovative solutions for acute patient care which are the result of a clear focus on core competencies, a close dialog with customers, over a century of experience in the market, and continuous investment in R&D. With U.S. headquarters in Telford, Pennsylvania and world headquarters in Lübeck, Germany, Dräger Medical employs nearly 6,000 people worldwide.
GE Healthcare provides solutions for tailored therapy that are helping shape a new age of patient care. Advance critical care ventilation and monitoring integration in the Engstrom Carestation features new breakthrough methods in ventilation monitoring with SpiroDynamiacs and FRC INview. Other solutions include a noninvasive and highly flexible approach to heliox therapy using the Aptaer Heliox Delivery System . And the Centiva/5 Critical Care Ventilator combines a compact size with high levels of performance. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE:GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.
